baber/WOPTO huggingface dataset:
Patent NZ-206120-A (NZ)
Title: 4-(6,7-dimethoxyquinazolin-4-yl)-semicarbazides
Inventor: RENTH E O
IPC: C07D239/94
Filed: 1983-11-01
Abstract: Compounds of the formula   <IMAGE>   wherein R1 is hydrogen, alkyl of 1 to 4 carbon atoms or trifluoromethyl; R2, R3 and R4 are each independently hydrogen, methyl or ethyl; R5 is hydrogen, alkyl of 1 to 8 carbon atoms, phenyl-(alkyl of 1 to 8 carbon atoms), cycloalkyl of 3 to 7 carbon atoms, (alkoxy of 1 to 4 carbon atoms) carbonyl-methyl, phenyl, substituted phenyl, naphthyl or substituted naphthyl; or R4 and R5, together with each other, are alkylene of 4 to 5 carbon atoms, optionally interrupted by -O- or -NR6-, where R6 is alkyl of 1 to 4 carbon atoms; and non-toxic, pharmacologically acceptable acid addition salts thereof. The compounds as well as their salts are useful as cardiotonics.
Patent NZ-214011-A (NZ)
Title: Dielectric material resin impregnated fluorocarbon fibres
Inventor: JOHNSON D D
IPC: H01B3/00
Filed: 1985-10-30
Abstract: Dielectric materials having low dielectric constant are provided, the materials comprising fabrics impregnated with theremosetting resins, at least a portion of the fibers in the fabrics being fluorocarbon fibers. Also provided is a method of manufacture of these dielectric materials. The dielectric materials are useful in the fabrication of multilayer printed circuit boards.
Patent NZ-221754-A (NZ)
Title: Production of ceramic bodies containing polymer component
Inventor: NEWKIRK MARC S
IPC: C04B41/48
Filed: 1987-09-09
Abstract: A method of producing self-supporting ceramic bodies (12) having a polymer component, which includes first providing a self-supporting ceramic body (12) comprising (i) a polycrystalline oxidation reaction product formed upon oxidation of a molten parent metal with an oxidant, and (ii) interconnected porosity (13) at least partially accessible from one or more surfaces of said ceramic body. The polymer is disposed or formed within the interconnected porosity (13). The polymer is situated so as to alter, modify or contribute to the properties of the ceramic body (12) originally formed.
Patent NZ-222278-A (NZ)
Title: Microencapsulated bioactive agent as an oral veterinary composition so as to protect agent against gastrointestinal degradation
Inventor: TICE T R
IPC: C07K16/44
Filed: 1987-10-22
Abstract: A method and formulation for orally administering a bioactive agent which comprises encapsulating the agent in one or more biodegradable and biocompatible polymer or copolymer excipients to form a microcapsule which is capable of passing through the gastrointestinal tract unaffected and being taken up by the Peyer's patch.
Patent NZ-226418-A (NZ)
Title: Packaging for flowers
Inventor: DE PAGTER JANUS ADRIAAN WILLEM
IPC: B65D85/50
Filed: 1988-09-30
Abstract: Packaging for flowers comprising a crate (1) and a box (2) to be placed on this crate with the base (3) at the top. The said box base (3) is removable or hingeable. This packaging is suitable for dry and wet packing of upright flowers. In the case of wet packing, the packaging cannot leak. By the easy removal or hinging of the box base, the packed flowers can be displayed from the top and this base can be replaced in the closed position without any problem. By removing the box, the tightly packed flowers will fan out, so that transfer to a bucket is not necessary.
Patent NZ-228711-A (NZ)
Title: 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
Inventor: OTTERNESS IVAN GEORGE
IPC: A61K31/40
Filed: 1989-04-12
Abstract: This invention relates to the use of certain 3-substituted-2-oxindole-1-carboxamides of the formula <CHEM> and the pharmaceutically-acceptable base salts thereof wherein X is H, Cl or F; Y is H or Cl; and R is benzyl or thienyl to inhibit interleukin-1 biosynthesis in a mammal. This invention also relates to the use of such compounds for treating interleukin-1 mediated disorders and dysfunctions such as bone and connective tissue metabolism disorders and immune dysfunction in a mammal. The methods of this invention comprise administering an interleukin-1 biosynthesis inhibiting amount of the compounds and salts of this invention to such a mammal.
Patent NZ-234130-A (NZ)
Title: Oxa- (or thia-)diazole- and triazole-substituted propargyl derivatives and
Inventor: ADAM CHI-TUNG HSU
IPC: A01N43/653
Filed: 1990-06-19
Abstract: Compounds of the formula <CHEM>  wherein  Y and Z are each independently O, S, or N-R;  X is H, Br or I; A and R is H, Br or I; are each independently one of; (C1 to C18) straight or branched alkyl; (C3 to C8) cycloalkyl; (C3 to C6) alkenyl; (C3 to C6) alkynyl except propargyl; (C7 to C12) aralkyl; (C6 to C12) aryl optionally substituted with one or more halogen, (C1 to C4) alkyl or haloalkyl, (C1 to C4) alkoxy, nitro, cyano, carboxyl (C1 to C4) alkoxycarbonyl, (C1 to C4) alkyl thio, -S(O)nR<2> where n is 1 or 2 and R2 is (C1-C4) alkyl; a 2-thienyl, 3-thienyl, 2-furyl, 3-furyl, 2-pyridyl, 3-pyridyl, or 4-pyridyl moiety each optionally substituted with halo or nitro; or H, with the proviso that R is H only when X is I or Br. are diclosed as useful microbicides and herbicides.
Patent NZ-250919-A (NZ)
Title: Benzoylguanidine derivatives; pharmaceutical compositions
Inventor: LANG HANS-JOCHEN
IPC: C07D217/24
Filed: 1994-02-18
Abstract: There are described benzoylguanidines of the formula I <IMAGE> where R(1) to R(3) are H, Hal, (cyclo)alkyl, N3, CN, or OH, alkyloxy, phenyl, phenoxy or benzoyl, and their pharmacologically acceptable salts, but with the exception of the compounds benzoylguanidine, 4-chlorobenzoylguanidine, 3,4-dichlorobenzoylguanidine and 3- or 4-methylbenzoylguanidine. They are obtained by reaction of a compound II <IMAGE> where L is a leaving group, with guanidine.t
Patent NZ-264327-A (NZ)
Title: Carboxylic acids, derivatives, carbamates, containing an aromatic ring; and pharmaceutical compositions thereof
Inventor: KLAUS MICHAEL
IPC: A61K9/12
Filed: 1994-08-29
Abstract: The compounds of the formula <IMAGE>  wherein R<1> is a radical of the formulae <IMAGE> and R<2>-R<10> have the meaning mentioned in the description, can be used as medicaments, particularly for dermatological and oncological indications.
Patent NZ-324299-A (NZ)
Title: Preparation of (11beta,16beta)-21-(3-carboxy-3-oxopropoxy)-11-hydroxy-2'-methy l-5 ' h-pregna-1,4-dieno[17,16-d]oxazole-3,20-dione
Inventor: FORTE LUIGI
IPC: C07J71/00
Filed: 1996-12-04
Abstract: A process for preparing the compound (11beta,16beta)-21-(3-CARBOXY-1-OXOPROPOXY)-11-HYDROXY-2'-METHYL-5'H-PREGNA-1,4-DIENO(17,16-D) OXAZOLE-3,20-DIONE which comprises reacting the compound (11beta,16beta)-11,21-DIHYDROXY-2'-METHYL-5'H-PREGNA-1, 4-DIENO(17,16-D)OXAZOLE-3,20-DIONE with succinic anhydride in a (C1-C4) alkyl ester of a (C1-C4) carboxylic acid as solvent, in the presence of a basic catalyst.
Patent NZ-331564-A (NZ)
Title: Washing machine, direct drive motor uses dynamic and regenerative braking
Inventor: SATORU MATSUMOTU
IPC: H02P6/17
Filed: 1998-08-26
Abstract: A washing machine bowl is driven by  a direct drive three phase motor 20 powered by inverter 47.  The motor circuitry is arranged so that the motor can be braked by a mix of dynamic, regenerative or short circuit braking.  Dynamic braking is achieved by passing regenerated current through resistor 49.  Short circuit braking is achieved by switching on switching elements 57b, 57d, 57f to short circuit the motor windings.  In regenerative braking the regenerated current is passed into capacitors 42a and 42b in the DC power supply 43.  The mix of braking modes is controlled by a microprocessor, and depends on the point in the washing or drying cycle the machine has reached.
Patent NZ-500079-A (NZ)
Title: Regulatory element for expressing genes in plants
Inventor: HODGES THOMAS K
IPC: C12N15/29
Filed: 1998-04-03
Abstract: SEQ ID:2 contains regulatory elements for expression of genes in eukaryotic cells.  A plant expression vector is provided that comprises the regulatory element of SEQ ID:2 operably linked to a non-natively associated gene.  This vector is used to produce transgenic plants.
Patent NZ-501192-A (NZ)
Title: Water going vessel hull design and method of determining
Inventor: SMITH DREXEL KERMIT
IPC: B63B9/00
Filed: 1998-05-29
Abstract: A method for displacement hull design of a water going vessel, the hull design variables being a hull shape, a wetted length, a beam, a wetted surface area, a residuary resistance, a prismatic coefficient, a block coefficient, a maximum beam coefficient and a water plane coefficient.  The hull is constrained to have a slenderness, which comprises the hull having a high ratio of the wetted length to the beam and the residuary resistance is minimized.  The hull shape is constrained such that the hull has the minimum wetted surface area for the hull slenderness.  Varying the prismatic coefficient, the block coefficient, the maximum beam coefficient and the water plane coefficient optimizes the hull shape. The design method can be applied to multihull water vessels.
Patent NZ-503933-A (NZ)
Title: Flexible lightweight protective pad with energy absorbing inserts
Inventor: TOMS DOUGLAS
IPC: A41D13/00
Filed: 1998-03-06
Abstract: Disclosed is a protective pad for protecting the human body against impact forces.  The pad is formed using layers of high-density closed-cell polymer foam, low-density closed-cell polymer foam, and resilient or non-resilient energy absorbing inserts.  The high-density layer absorbs and shunts impact forces, while the low density layer acts as a cushion against the human body and provides for comfort.  The pad (10) can be provided with a plurality of holes through its thickness to provide for breathability and release of heat from the human body, the surface area of the holes (12) being great enough to allow for adequate ventilation but not so great as to significantly decrease the protection offered by the pad.  The pad can also be provided with a plurality of score lines (14) across its surface and partially through its thickness to provide for flexibility and conformability to the part of the human body being protected.
Patent NZ-504461-A (NZ)
Title: Pseudopolymorphic forms of efletirizine
Inventor: BERWAER MONIQUE
IPC: A61P37/08
Filed: 1998-11-26
Abstract: Pseudopolymorphic forms of 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride, specifically, anyhydrous 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride and 2-[2-[4-[bis(4-fluorophenyl)methyl]-1-piperazinyl]ethoxy]acetic acid dihydrochloride monohydrate. The processes for preparing such compounds are also described.
Patent NZ-504706-A (NZ)
Title: Substituted isoquinoline derivatives and their use as anticonvulsants
Inventor: PORTER RODERICK ALAN
IPC: A61P25/06
Filed: 1998-12-16
Abstract: A compound of formula (I) or pharmaceutically acceptable salt or solvate thereof: where Q is a monocyclic or bicyclic aryl or heteroaryl ring, R1 is hydrogen, C1-6 alkyl (optionally substituted by hydroxy or C1-4 alkoxy), C1-6 alkenyl, C1-6 alkynyl, C1-6 alkylCO, formyl, CF3CO or C1-6 alkylSO2, R2 is hydrogen or up to three substituents selected from halogen, NO2, CN, N3, CF3 O, CF3S, CF3CO, tifluoromethyldiazirinyl, C1-6 alkyl, C1-6 alkenyl, C1-6 alkynyl, C1-6 perfluoroalkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C1-6 alkylO, C1-6 alkylCO, C3-6 cycloalkylO, C3-6 cycloalkylCO, C3-6 cycloalkylC1-4 alkylO, C3-6 cycloalkylC1-4 alkylCO, phenyl, phenoxy, benzyloxy, benzoyl, phenyl-C1-4 alkyl, C1-6 alkylS, C1-6 alkylSO2, (C1-4 alkyl)2 NSO2, (C1-4 alkyl)NHSO2, (C1-4 alkyl)2 NCO, (C1-4 alkyl)NHCO, CONH2, CF3 SO2, C1-6 alkenyl, C1-6 alkynyl or C1-6 hydroxyalkyl; or NR3 R4 where R3 is hydrogen or C1-4 alkyl, and R4 is hydrogen, C1-4 alkyl, formyl, CO2C1-4 alkyl or COC1-4 alkyl; or two R2 groups together form a carbocyclic ring that is saturated or unsaturated and unsubstituted or substituted by OH or a"O; and X is halogen, C1-6 alkoxy, C1-6 alkyl, C2-6 alkenyl optionally substituted by phenyl. These compounds are useful as anticonvulsant agents.
Patent NZ-506484-A (NZ)
Title: A method of preparing a thermo-stable biodegradable biological storage for inoculating seeds with microorganisms
Inventor: JOHNSON VON WALTER
IPC: A01C1/08
Filed: 2000-08-22
Abstract: A method of producing a thermo-stable biodegradable medium for storage of biological materials includes: a) preparing a mixture of at least one biopolymer at a concentration of 100-10% by weight of the mixture at a temperature of 5-40OC; the mixture is either a solid or a suspension; b) preparing a concentrate of the biological materials of 10-100% by weight; the concentrate is either a solid or a suspension; c) combining the mixture of step a) and the concentrate of step b) to form a second mix and d) agitating the second mixture at a temperature of 5-40oC to form a homogeneous suspension wherein a gel is formed. The biopolymer is xanthan gum, acacia gum, guar gum, gellan or starch.  The biological material is a bio-inoculant, microorganism, biological cells or parts thereof, vaccine, pharmaceutical compound or composition, enzyme, hormone, protein, biochemical, biologically unstable composition, or a chemical composition. A liquid spray containing the medium prepared above is used to inoculate plant seed.  The medium can also be added to an irrigation system.
Patent NZ-507260-A (NZ)
Title: Arrangement and method to apply diffusing wave spectroscopy to measure the properties of multi-phase systems, as well as the changes therein
Inventor: DE KRUIF CORNELIS GIJSBERTUS
IPC: G01N21/47
Filed: 1999-04-06
Abstract: Method and arrangement for measuring the properties of multi-phase systems as well as the changes therein, such as changing interactions between particles in a solution. The arrangement having laser means (1) for producing a laser beam (2). A single source fibre (5) having a first end arranged for receiving the laser beam (2) and a second end arranged for emitting laser light in a multi-phase system (7). At least one detector fibre (8(1), 8(2), ...) arranged for detecting the laser light after being scattered by the multi-phase system (7). Processing means arranged for receiving an output signal from the at least one detector fibre and for calculating predetermined parameters with respect to the multi-phase system (7). Any one of the at least one detector fibre (8(1), 8(2), ...) being located at predetermined locations with respect to the second end of the source fibre (5).
Patent NZ-507504-A (NZ)
Title: Methods for treating hot flashes and gynaecomastia
Inventor: GARNICK MARC B
IPC: A61K38/09
Filed: 1999-04-27
Abstract: The use of luteinizing hormone release hormone (LHRH) antagonists for inhibiting or treating hot flashes or gynaecomastia in a subject.
Patent NZ-513914-A (NZ)
Title: Dry powder delivery system apparatus
Inventor: LEEDOM MARVIN A
IPC: A61M15/00
Filed: 1998-09-16
Abstract: A powder delivery system comprising: -a body having an internal cavity and an outlet port for delivering a powder into an aerosol form -a substrate in the cavity with at least one aliquot of powder at a corresponding aliquot location on the substrate, the at least one aliquot being sealed under a corresponding separate, discrete individually releasable cover in a cover close position, the cover having memory and favoring a predetermined memory configuration and; -means for selectively causing the cover to displace to a cover open favoured memory configuration.
Patent NZ-515122-A (NZ)
Title: Multi-layered impact resistant ply and composite
Inventor: HENDERSON WILLIAM J
IPC: F41H5/04
Filed: 2000-04-14
Abstract: One embodiment is a ballistic resistant fibrous ply including two or more layers of a fibrous network (12), each fibrous network having a plurality of unidirectional oriented fibers, when adjacent layers are aligned, the fibers in adjacent fibrous networks (12) arranged at an acute angle (Ò) that is less than 25_ to each other. An alternative embodiment disclosed is a ballistic resistant composite including two or more layers of a fibrous ply, each fibrous ply having a plurality of unidirectional oriented fibers. When the layers of plies are aligned, the fibers in adjacent fibrous plies are arranged at an acute angle to each other.
Patent NZ-516640-A (NZ)
Title: Image presentation and scale merging system
Inventor: HOBAN SALLY
IPC: G06T3/40
Filed: 2002-01-16
Abstract: A computerised method of automated product selection, includes a)Capturing in one or more databases at least a first product image of a first product and at least a further image of a further item. b)A product selection system, which includes a server for receiving and serving images and one or more capture devices, in communication with the server. The server includes a processing unit and associated memory device for storing a computer program causing the processing unit to determine the dimensions of the first product and the further item from each captured image. b)Facilitating product selection based on the matching by the processing unit, of the dimension of both captured images along one or more reference axes in each image. The processing unit uses the dimensions and at least one reference axis of each captured image to combine the captured images in to a merged image, which is displayed to the customer using one or more terminals.
Patent NZ-522656-A (NZ)
Title: Printed thermoplastic film with radiation-cured overprint varnish for packaging food products
Inventor: MOSSBROOK MENDY J
IPC: C08J7/04
Filed: 2001-06-05
Abstract: A packaged food product that includes a food product and a package enclosing the food product is disclosed, wherein: the package may be formed from a coated, printed film that includes a substrate film including one or more thermoplastic materials and having an average thickness of less than about 15 mils. An image is printed on the print side of the substrate film. A radiation-cured varnish covers the printed image. The radiation-cured varnish is formed by: coating the printed image with a radiation-curable varnish that includes one or more polymerizable reactants and optionally one or more photoinitiators. The radiation-curable varnish is subsequently exposed to radiation sufficient to polymerize at least 90 weight % of the polymerizable reactants. When the coated, printed film is tested according to the FDA migration test protocol, no more than 50 parts per billion total of any of the polymerizable reactants and the optional photoinitiators migrate within 10 days at the 40 DEG C from the coated, printed film into a food simulant of 95 weight % ethanol and 5 weight % water enclosed within a test container formed from the coated, printed film so that the food simulant contacts the food side of the substrate film and the ratio of volume of food simulant to surface area of coated, printed film is 10 milliliters per square inch.
Patent NZ-526337-A (NZ)
Title: Method of making preforms that does not require the use of solvents, uses fewer components and that can assume a variety of shapes
Inventor: BOYD MATTHEW
IPC: B29C70/38
Filed: 2002-01-08
Abstract: A method of preparing fibre preforms (18) is described. The method disperses fibres and binder (14) on a forming support surface such that the materials are conditioned and then applied to the surface where the composite material solidifies. Reinforcing material, such as fibreglass, is mixed with the binder, such as thermoplastic or thermoset materials, so that the materials adhere. Then, the adhesive mixture is dispersed in a controlled pre-determined weight ratio on the support surface where the mixture sticks to the support surface, cools and solidifies. The deposited mixture can also be shaped further into a final desired shape before complete solidification. This process does not require a vacuum or plenum system to hold the reinforcing material in place. The preform can be made in any shape, including sections or asymmetric configurations. As seen in the figure, a preform making assembly (10) used to practice the method described includes a materials applicator (12) that applies the preform material mixture (14) to a support surface (16) to create the preform (18). Such a preform (18) can be used within a mould or as a part of the mould support structure. For example, preform (18) could be placed within a closed mould or on an open mould (a tray or base, for example) to form the composite part. Alternatively, preform (18) could be used as a base structure having materials attached or moulded to it, thus acting as a skeleton or tray and eliminating the need for a mould base or moulding tool. Preform (18) can be any desired shape.
Patent NZ-529036-A (NZ)
Title: Hypersulfated disaccharides and methods of using the same for the treatment of inflammations
Inventor: AHMED TAHIR
IPC: A61P19/02
Filed: 2002-04-16
Abstract: Disclosed are compounds of the formula (I), wherein; R1, R2, R3, R4, R5, and R6 are either SO3-, PO3- or H; and wherein at least three of the group consisting of R1, R2, R3, R4, R5, and R6 are each independently either SO3-, or PO3-; provided that if R3, and R4 are both SO3- then at least one of the group consisting of R1, R2, R5, and R6 are either SO3-, or PO3-; or R3, R4, R5, are SO3-, then at least one of the group consisting of R1, R2, and R6 are either SO3-, or PO3-; or R1, and R4, are both SO3- and R3 is not SO3-, then at least one of the group consisting of R2, R5, and R6 are either SO3-, or PO3. Further disclosed is the use of compounds of formula (I) in the preparation of a medicament for treating or alleviating the symptoms of inflammatory reactions in a mammalian patient with the proviso that if only R3, R4, R5are SO3- in any compound then said medicament is enriched for said compound.
Patent NZ-536838-A (NZ)
Title: Pharmaceutical preparations for oral administration, containing ion-exchange resins loaded with active ingredients and intrinsically viscous gelling agents as thickening agents
Inventor: MERTIN DIRK
Filed: 2003-05-19
Abstract: Pharmaceutical preparations for oral administration that contain pradofloxacin (8-cyano-1-cyclopropyl-7-((1S,6S)-2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acids) as the active ingredient which is bound to an ion exchanger are disclosed, wherein the loaded ion exchanger is dispersed in a carrier medium comprising at least one pseudoplastic gel former (such as polyacrylic acid, xanthan, microcrystalline cellulose, cellulose ether, bentonite, highly disperse silica or a mixture of these gel formers). These preparations may also contain an intrinsically viscous gelling agent as a thickening agent in order to improve their physical stability and acceptance, especially by animals.
Patent NZ-538707-A (NZ)
Title: Transmucosal pharmaceutical administration form for treating the abuse of and dependence on addictive drugs
Inventor: HOFFMANN HANS-RAINER
Filed: 2003-10-17
Abstract: Planiform transmucosal pharmaceutical administration forms are disclosed, which comprise of a solid solution of the active ingredient in a phosphatidylcholine fraction in which the fatty acid residues are at least 90% saturated; or a mixture of said phosphatidylcholine fraction in which the fatty acid residues are at least 90% saturated, with a copolymer of maleic acid and an alkyl vinyl ether. The administration forms are characterised by a low solubility in the buccal cavity, which gives a rapid and constant active ingredient release over an extended period. These administration forms are particularly suitable for the treatment of the abuse of and dependence on addictive drugs.